Company Overview

Lotus started a new phase of growth in 2014 when Alvogen, a next generation pharmaceutical company, became a majority shareholder and chose Taiwan as its Regional Asian Headquarters. Lotus now is a fast growing specialty generic company in Asia. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Through its majority shareholder Alvogen, Lotus has access to markets in the USA, Central Eastern Europe and Asia, while on its own Lotus has presence in Asia in Korea, Taiwan, China, India and exports to Japan and South East Asia.

Development Projects
25
Pending ANDA filings
5

Asia Pacific Footprints

Broad range of countries

Being the regional hub in Asia Pacific of Alvogen, Lotus’ international footprints currently encompass a broad range of countries including Korea, Myanmar, Thailand, Vietnam, Philippines, Singapore, Malaysia, Hong Kong,China, through its own and Alvogen’s affiliates, with headquarters in Taiwan. Lotus has manufacturing and R&D hubs in Taiwan and Korea.

Operations in Asia

Meet management

LEADERSHIP TEAM

Lotus is led by a globally experienced management team. With support from Alvogen, Lotus management is poised to lead Lotus to become a leading generic company among the top 5 in Asia.

Leadership

Alvogen Partnership 

Alvogen currently has commercial operations in 35 countries around the globe, with regional hubs based in North America, Romania, and Taiwan, and is ready well advanced in the field of biopharmaceuticals and currently markets several biosimilars in selected regions through strategic alliances. Over US$500 million are being invested in the development of monoclonal antibodies and state-of-the-art manufacturing capabilities, and the team is committed to continuing to grow our business around the world and to becoming a top 10 global generic pharmaceuticals player. 

Visit Alvogen

Among the top 5 in Asia

Our passionate team is committed to continue to grow our business and we aim to become a leading generic company among the top 5 in Asia.

CONNECT WITH LOCAL TEAMS

Lotus has operations in 10 countries within Asian region through its own and Alvogen’s affiliates, with manufacturing and R&D capabilities in Taiwan and Korea.

Connect with local teams to learn more about product offering in your region.

Operations in Asia